Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$97.89
pos +0.00
+0.00%
Today's Range: 96.40 - 101.94 | CELG Avg Daily Volume: 5,855,900
Last Update: 02/05/16 - 3:59 PM EST
Volume: 0
YTD Performance: -18.27%
Open: $0.00
Previous Close: $101.93
52 Week Range: $92.98 - $140.72
Oustanding Shares: 785,654,567
Market Cap: 80,081,770,014
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 12 13 12
Moderate Buy 1 1 1 1
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.31 1.33 1.31 1.33
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 21.64
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
21.64 85.40 30.32
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-18.74% -18.44% 96.23%
GROWTH 12 Mo 3 Yr CAGR
Revenue 18.10 0.58 0.16
Net Income 37.90 0.52 0.15
EPS 42.00 0.72 0.20
Earnings for CELG:
EBITDA 2.94B
Revenue 7.67B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $1.05 $1.15 $4.75 $6.52
Number of Analysts 2 2 2 1
High Estimate $1.11 $1.20 $4.94 $6.52
Low Estimate $0.99 $1.10 $4.56 $6.52
Prior Year $0.95 $1.08 $4.08 $4.75
Growth Rate (Year over Year) 10.53% 6.48% 16.42% 37.26%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Bruce Kamich

 | Jan 29, 2016 | 12:00 PM EST

We anticipate that price rallies in the prior support area ($105 to $110) fail and become new resistance. 

bearishCelgene estimates, target cut at Jefferies

Jan 29, 2016 | 7:13 AM EST

Shares of CELG now seen reaching $146, according to Jefferies. Estimates also reduced, given currency headwinds. Buy rating. 

By

Bret Jensen

 | Jan 26, 2016 | 10:00 AM EST

Celgene, AbbVie and Gilead are set to report earnings. Here's what to look for.

By

Jim Cramer

 | Jan 21, 2016 | 12:39 PM EST

TheStreet's Jim Cramer says Palo Alto Networks is the best way to play the security market.

By

Jim Cramer

 | Jan 11, 2016 | 6:24 PM EST

We need some cooperation from China and oil. Please.

By

Jim Cramer

 | Jan 11, 2016 | 11:33 AM EST

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Celgene (CELG) has a great deal of earnings potential in 2017, 'so it's a buy.'

By

Timothy Collins

 | Jan 11, 2016 | 11:20 AM EST

Many say you should never sell puts, but there are times when it can work.

updateJP Morgan Healthcare Conf.

Jan 11, 2016 | 7:06 AM EST

JPMorgan Healthcare Conference (Day 1 of 5) - 01/11/16 - 01/15/16 San Francisco, CA

By

Jim Cramer

 | Jan 4, 2016 | 12:12 PM EST

Jim Cramer says don't rush into the stock market in Monday's trading session looking for bargains in the midst of a selloff.

By

Bret Jensen

 | Jan 4, 2016 | 11:00 AM EST

5 biotech stocks that could outperform the overall market in 2016.

On a fun note these are my two choices for the best Super Bowl Ads on Sunday: 1. I am bias...
The sharp decline in the index in the first half of January and then the reflexive bounce ...

Nice work on the diary today, Bret. Tough day but you killed it.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.